НОВОСТИ
NOVARTIS IS A PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION
Novartis is an international pharmaceutical company headquartered in Basel, Switzerland. The company’s subdivisions, factories and research centres are located in different countries throughout the world and incorporate more than 110…
AKRIKHIN TO PARTNER THE VI ALL-RUSSIAN GMP CONFERENCE 2021
AKRIKHIN is one of the leading Russian pharmaceutical companies producing high-quality medicines of therapeutic groups most demanded in Russia: dermatology, cardiology, neurology, gynaecology, pulmonology, endocrinology, and others. The company’s product…
PRO.MED.CS PRAHA A.S. TO SUPPORT A SESSION DEDICATED TO THE CIRCULATION OF PHARMACEUTICALS IN THE EAEU
In 2019, Czech Republic’s leading pharmaceutical company PRO.MED.CS Praha a.s. celebrated its 30th anniversary. Today, this manufacturer supplies products to more than 25 countries, primarily, to the Russian Federation, Central and Eastern…
ABBOTT WILL SUPPORT THE PANEL DISCUSSION “INTERDISCIPLINARY APPROACH TO GOOD PRACTICES REGULATION”.
In 2019, Czech Republic’s leading pharmaceutical company PRO.MED.CS Praha a.s. celebrated its 30th anniversary. Today, this manufacturer supplies products to more than 25 countries, primarily, to the Russian Federation, Central and Eastern…
TEVA TO SHARE ITS PHARMACEUTICAL QUALITY AND SAFETY EXPERT REVIEW
In 2021, Teva in partnership with the 6th All-Russian GMP Conference involving international participants will present its experience and participate in discussions at the St. Petersburg site. Teva is one of…
AMGEN. OUR MISSION: TO SERVE PATIENTS
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools…
PHARMECO GROUP OF COMPANIES IS A SPECIAL PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION
Pharmeco GC is a Russian pharmaceutical vertically integrated group of companies operating in all the main segments of the pharmaceutical industry – scientific research and development, production and distribution of…
NOVO NORDISK BECOMES A PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION
Novo Nordisk is a global pharmaceutical company founded in Denmark in 1923 and the world’s leader in the development and manufacture of drugs for the treatment of diabetes and obesity.…
GEDEON RICHTER STARTS PRODUCING IN RUSSIA AN INNOVATIVE DRUG FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER
Gedeon Richter Ltd. launches production of Reagila (cariprazine) for patients suffering schizophrenia and bipolar disorder in Russia. Starting from July 26, 2021, the drug will be produced at the GEDEON…
GMP CONFERENCE ORGANIZERS EXPECTING TO RECEIVE QUESTIONS FROM PHARMACEUTICAL INDUSTRY REPRESENTATIVES RELATED TO TECHNOLOGY TRANSFER
On 24 September 2021, on the third day of the 6th All-Russian GMP Conference with International Participants, traditional master classes will take place, which will allow to gain new knowledge…
Результатов не найдено.